Xencor Inc (XNCR) stock
XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.39−0.11 (-0.32%)
Close on Nov 18, 2026Market cap $2.56BP/E –Yield –
Xencor EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Xencor's EV/EBITDA was 31.6× on Jan 31, 2023, against 62.5× a year earlier. Over the last 3 years it ranged from 13.3× to 72.8×, with a median of 28.5×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jan 31, 2023 | 31.6× | +6.8 |
| 2022 | Dec 30, 2022 | 24.9× | −37.7 |
| 2020 | Apr 30, 2020 | 62.5× | +11.1 |
| 2019 | Dec 31, 2019 | 51.5× | −13.0 |
| 2017 | Jul 31, 2017 | 64.5× | +40.8 |
| 2016 | Dec 30, 2016 | 23.7× | – |
See a number that looks wrong?